SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITY EXCHANGE ACT OF 1934
Date of report September 12, 1997
------------------------------------------------------------------
NPS PHARMACEUTICALS, INC.
- --------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Its Charter)
Delaware
- --------------------------------------------------------------------------------
(State or Other Jurisdiction of Incorporation)
0-23272 87-0439579
- ----------------------------- ----------------------------------------
(Commission File Number) (I.R.S. Employer Identification No.)
420 Chipeta Way, Salt Lake City, Utah 84108-1256
- --------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(801) 583-4939
- --------------------------------------------------------------------------------
(Registrant's Telephone Number, Including Area Code)
N/A
- --------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
ITEM 5. OTHER EVENTS.
On September 11, 1997, NPS Pharmaceuticals, Inc. (the "Company")
announced that Amgen Inc. ("Amgen") will update its strategy for the ongoing
development of the Company's novel drugs, referred to as "calcimimetics" for
treating primary and secondary hyperparathyroidism. The press release
announcing the update is filed herewith as Exhibit 99.1.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS.
c. Exhibits
99.1 Press Release dated September 11, 1997 and titled "Amgen
and NPS to Update Calcimimetics Development Plan."
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
NPS PHARMACEUTICALS, INC.
Date: September 12, 1997 /s/ JAMES U. JENSEN
-------------------------------
James U. Jensen, Vice President
2
INDEX TO EXHIBITS
Sequentially
Exhibit Number Description Numbered Page
- -------------- ----------- -------------
99.1 Press Release dated September 11, 1997 and titled "Amgen
and NPS to Update Calcimimetics Development Plan."
3